MedCity News December 20, 2023
Spending on prescription drugs for autoimmune diseases has increased by 459% over the past decade, even surpassing cancer drugs. Yet despite driving around 30% of employers’ entire prescription spend, autoimmune diseases have remained completely overlooked in employer health spend.
The recent explosion of buzzy (and expensive) weight-loss drugs like Ozempic has many employers worried about the potential price tags associated with covering the costs. As they should be: employer health care spend is currently rising at the steepest rate seen in years.
But while employers fret over the price of these drugs and scramble to reduce spend, there’s a much costlier epidemic they’re largely ignoring: autoimmune disease. This group of health conditions affect around 1 in 5 Americans – a...
Today's Sponsors
Today's Sponsor